APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mucin 1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mucin 1 Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchMucin 1 Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Mucin 1 Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Mucin 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mucin 1 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Mucin 1 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Mucin 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mucin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mucin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mucin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mucin 1 include Merck KGaA, Vaxil Bio Therapeutics Ltd, Transgene SA, Minerva Biotechnologies Corp, GeoVax Labs Inc, Etubics Corp, Boehringer Ingelheim GmbH, Bavarian Nordic A/S and Akshaya Bio Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mucin 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mucin 1 market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mucin 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mucin 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mucin 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mucin 1 Market by Company

Merck KGaA

Vaxil Bio Therapeutics Ltd

Transgene SA

Minerva Biotechnologies Corp

GeoVax Labs Inc

Etubics Corp

Boehringer Ingelheim GmbH

Bavarian Nordic A/S

Akshaya Bio Inc

Mucin 1 Segment by Type

TG-4010

BI-1361849

GO-2032c

ImMucin

Others

Mucin 1 Segment by Application

Colon Cancer

Ovarian Cancer

Prostate Cancer

Breast Cancer

Others

Mucin 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mucin 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mucin 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mucin 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mucin 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mucin 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of TG-4010 Table 2. Major Company of BI-1361849 Table 3. Major Company of GO-2032c Table 4. Major Company of ImMucin Table 5. Major Company of Others Table 6. Global Mucin 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Mucin 1 Sales by Type (2021-2026) & (k units) Table 8. Global Mucin 1 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Mucin 1 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Mucin 1 Sales Market Share in Value by Type (2021-2026) Table 11. Global Mucin 1 Price by Type (2021-2026) & (US$/unit) Table 12. Global Mucin 1 Sales by Type (2027-2032) & (k units) Table 13. Global Mucin 1 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Mucin 1 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Mucin 1 Sales Market Share in Value by Type (2027-2032) Table 16. Global Mucin 1 Price by Type (2027-2032) & (US$/unit) Table 17. North America Mucin 1 Sales by Type (2021-2026) & (k units) Table 18. North America Mucin 1 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Mucin 1 Sales by Type (2021-2026) & (k units) Table 20. Europe Mucin 1 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Mucin 1 Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Mucin 1 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Mucin 1 Sales by Type (2021-2026) & (k units) Table 24. Latin America Mucin 1 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Mucin 1 Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Mucin 1 Sales by Type (2021-2026) & (US$ Million) Table 27. Mucin 1 Industry Trends Table 28. Mucin 1 Industry Drivers Table 29. Mucin 1 Industry Opportunities and Challenges Table 30. Mucin 1 Industry Restraints Table 31. Global Mucin 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Mucin 1 Revenue Market Share by Company (2021-2026) Table 33. Global Mucin 1 Sales by Company (2021-2026) & (k units) Table 34. Global Mucin 1 Sales Share by Company (2021-2026) Table 35. Global Mucin 1 Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Mucin 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Mucin 1 Major Company Production Sites and Headquarters Table 38. Global Mucin 1 Company, Product Type & Application Table 39. Global Mucin 1 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Mucin 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Mucin 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Mucin 1 Sales by Region (2021-2026) & (k units) Table 44. Global Mucin 1 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Mucin 1 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Mucin 1 Sales Market Share in Value by Region (2021-2026) Table 47. Global Mucin 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Mucin 1 Sales by Region (2027-2032) & (k units) Table 49. Global Mucin 1 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Mucin 1 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Mucin 1 Sales Market Share in Value by Region (2027-2032) Table 52. Global Mucin 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Mucin 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Mucin 1 Sales by Application (2021-2026) & (k units) Table 55. Global Mucin 1 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Mucin 1 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Mucin 1 Sales Market Share in Value by Application (2021-2026) Table 58. Global Mucin 1 Price by Application (2021-2026) & (US$/unit) Table 59. Global Mucin 1 Sales by Application (2027-2032) & (k units) Table 60. Global Mucin 1 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Mucin 1 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Mucin 1 Sales Market Share in Value by Application (2027-2032) Table 63. Global Mucin 1 Price by Application (2027-2032) & (US$/unit) Table 64. North America Mucin 1 Sales by Application (2021-2026) & (k units) Table 65. North America Mucin 1 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Mucin 1 Sales by Application (2021-2026) & (k units) Table 67. Europe Mucin 1 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Mucin 1 Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Mucin 1 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Mucin 1 Sales by Application (2021-2026) & (k units) Table 71. Latin America Mucin 1 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Mucin 1 Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Mucin 1 Sales by Application (2021-2026) & (US$ Million) Table 74. Merck KGaA Company Information Table 75. Merck KGaA Business Overview Table 76. Merck KGaA Mucin 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck KGaA Mucin 1 Product Portfolio Table 78. Merck KGaA Recent Development Table 79. Vaxil Bio Therapeutics Ltd Company Information Table 80. Vaxil Bio Therapeutics Ltd Business Overview Table 81. Vaxil Bio Therapeutics Ltd Mucin 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Vaxil Bio Therapeutics Ltd Mucin 1 Product Portfolio Table 83. Vaxil Bio Therapeutics Ltd Recent Development Table 84. Transgene SA Company Information Table 85. Transgene SA Business Overview Table 86. Transgene SA Mucin 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Transgene SA Mucin 1 Product Portfolio Table 88. Transgene SA Recent Development Table 89. Minerva Biotechnologies Corp Company Information Table 90. Minerva Biotechnologies Corp Business Overview Table 91. Minerva Biotechnologies Corp Mucin 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Minerva Biotechnologies Corp Mucin 1 Product Portfolio Table 93. Minerva Biotechnologies Corp Recent Development Table 94. GeoVax Labs Inc Company Information Table 95. GeoVax Labs Inc Business Overview Table 96. GeoVax Labs Inc Mucin 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. GeoVax Labs Inc Mucin 1 Product Portfolio Table 98. GeoVax Labs Inc Recent Development Table 99. Etubics Corp Company Information Table 100. Etubics Corp Business Overview Table 101. Etubics Corp Mucin 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Etubics Corp Mucin 1 Product Portfolio Table 103. Etubics Corp Recent Development Table 104. Boehringer Ingelheim GmbH Company Information Table 105. Boehringer Ingelheim GmbH Business Overview Table 106. Boehringer Ingelheim GmbH Mucin 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Boehringer Ingelheim GmbH Mucin 1 Product Portfolio Table 108. Boehringer Ingelheim GmbH Recent Development Table 109. Bavarian Nordic A/S Company Information Table 110. Bavarian Nordic A/S Business Overview Table 111. Bavarian Nordic A/S Mucin 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Bavarian Nordic A/S Mucin 1 Product Portfolio Table 113. Bavarian Nordic A/S Recent Development Table 114. Akshaya Bio Inc Company Information Table 115. Akshaya Bio Inc Business Overview Table 116. Akshaya Bio Inc Mucin 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Akshaya Bio Inc Mucin 1 Product Portfolio Table 118. Akshaya Bio Inc Recent Development Table 119. North America Mucin 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. North America Mucin 1 Sales by Country (2021-2026) & (k units) Table 121. North America Mucin 1 Sales Market Share by Country (2021-2026) Table 122. North America Mucin 1 Sales Forecast by Country (2027-2032) & (k units) Table 123. North America Mucin 1 Sales Market Share Forecast by Country (2027-2032) Table 124. North America Mucin 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Mucin 1 Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Mucin 1 Market Share by Country (2021-2026) Table 127. North America Mucin 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Mucin 1 Market Share Forecast by Country (2027-2032) Table 129. Europe Mucin 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Europe Mucin 1 Sales by Country (2021-2026) & (k units) Table 131. Europe Mucin 1 Sales Market Share by Country (2021-2026) Table 132. Europe Mucin 1 Sales Forecast by Country (2027-2032) & (k units) Table 133. Europe Mucin 1 Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Mucin 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Mucin 1 Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Mucin 1 Market Share by Country (2021-2026) Table 137. Europe Mucin 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Mucin 1 Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Mucin 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Mucin 1 Sales by Country (2021-2026) & (k units) Table 141. Asia-Pacific Mucin 1 Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Mucin 1 Sales Forecast by Country (2027-2032) & (k units) Table 143. Asia-Pacific Mucin 1 Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Mucin 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Mucin 1 Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Mucin 1 Market Share by Country (2021-2026) Table 147. Asia-Pacific Mucin 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Mucin 1 Market Share Forecast by Country (2027-2032) Table 149. Latin America Mucin 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Latin America Mucin 1 Sales by Country (2021-2026) & (k units) Table 151. Latin America Mucin 1 Sales Market Share by Country (2021-2026) Table 152. Latin America Mucin 1 Sales Forecast by Country (2027-2032) & (k units) Table 153. Latin America Mucin 1 Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Mucin 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Mucin 1 Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Mucin 1 Market Share by Country (2021-2026) Table 157. Latin America Mucin 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Mucin 1 Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Mucin 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Mucin 1 Sales by Country (2021-2026) & (k units) Table 161. Middle East and Africa Mucin 1 Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Mucin 1 Sales Forecast by Country (2027-2032) & (k units) Table 163. Middle East and Africa Mucin 1 Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Mucin 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Mucin 1 Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Mucin 1 Market Share by Country (2021-2026) Table 167. Middle East and Africa Mucin 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Mucin 1 Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Mucin 1 Distributors List Table 172. Mucin 1 Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Mucin 1 Image Figure 2. Global Mucin 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mucin 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Mucin 1 Sales (2021-2032) & (k units) Figure 5. TG-4010 Image Figure 6. Global TG-4010 Sales YoY Growth (2021-2032) & (k units) Figure 7. BI-1361849 Image Figure 8. Global BI-1361849 Sales YoY Growth (2021-2032) & (k units) Figure 9. GO-2032c Image Figure 10. Global GO-2032c Sales YoY Growth (2021-2032) & (k units) Figure 11. ImMucin Image Figure 12. Global ImMucin Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Mucin 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Mucin 1 Market Share by Type 2025 VS 2032 Figure 17. North America Mucin 1 Sales Market Share in Volume by Type in 2025 Figure 18. North America Mucin 1 Sales Market Share in Value by Type in 2025 Figure 19. Europe Mucin 1 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Mucin 1 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Mucin 1 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Mucin 1 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Mucin 1 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Mucin 1 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Mucin 1 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Mucin 1 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Mucin 1 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Colon Cancer Image Figure 30. Global Colon Cancer Sales YoY Growth (2021-2032) & (k units) Figure 31. Ovarian Cancer Image Figure 32. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (k units) Figure 33. Prostate Cancer Image Figure 34. Global Prostate Cancer Sales YoY Growth (2021-2032) & (k units) Figure 35. Breast Cancer Image Figure 36. Global Breast Cancer Sales YoY Growth (2021-2032) & (k units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Mucin 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Mucin 1 Market Share by Application 2025 VS 2032 Figure 41. North America Mucin 1 Sales Market Share in Volume by Application in 2025 Figure 42. North America Mucin 1 Sales Market Share in Value by Application in 2025 Figure 43. Europe Mucin 1 Sales Market Share in Volume by Application in 2025 Figure 44. Europe Mucin 1 Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Mucin 1 Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Mucin 1 Sales Market Share in Value by Application in 2025 Figure 47. Latin America Mucin 1 Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Mucin 1 Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Mucin 1 Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Mucin 1 Sales Market Share in Value by Application in 2025 Figure 51. North America Mucin 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Mucin 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Mucin 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Mucin 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Mucin 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Mucin 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Mucin 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Mucin 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Mucin 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Mucin 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Mucin 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Mucin 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Mucin 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Mucin 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Mucin 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Mucin 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Mucin 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Mucin 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Mucin 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Mucin 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Mucin 1 Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Mucin 1 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • TG-4010
  • BI-1361849
  • GO-2032c
  • ImMucin
  • Others
Applications
  • Colon Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Breast Cancer
  • Others
Companies covered
  • Merck KGaA
  • Vaxil Bio Therapeutics Ltd
  • Transgene SA
  • Minerva Biotechnologies Corp
  • GeoVax Labs Inc
  • Etubics Corp
  • Boehringer Ingelheim GmbH
  • Bavarian Nordic A/S
  • Akshaya Bio Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mucin 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mucin 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mucin 1 Market by Type
  6. 1.3.1 TG-4010
  7. 1.3.2 BI-1361849
  8. 1.3.3 GO-2032c
  9. 1.3.4 ImMucin
  10. 1.3.5 Others
  11. 1.4 Global Mucin 1 Market Size by Type
  12. 1.4.1 Global Mucin 1 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Mucin 1 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Mucin 1 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Mucin 1 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Mucin 1 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Mucin 1 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Mucin 1 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Mucin 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mucin 1 Industry Trends
  2. 2.2 Mucin 1 Industry Drivers
  3. 2.3 Mucin 1 Industry Opportunities and Challenges
  4. 2.4 Mucin 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mucin 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Mucin 1 Sales (2021-2026)
  3. 3.3 Global Top Players by Mucin 1 Price (2021-2026)
  4. 3.4 Global Mucin 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mucin 1 Major Company Production Sites & Headquarters
  6. 3.6 Global Mucin 1 Company, Product Type & Application
  7. 3.7 Global Mucin 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mucin 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mucin 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mucin 1 Tier 1, Tier 2, and Tier 3
4 Mucin 1 Regional Status and Outlook
  1. 4.1 Global Mucin 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mucin 1 Historic Market Size by Region
  3. 4.2.1 Global Mucin 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mucin 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mucin 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mucin 1 Forecasted Market Size by Region
  7. 4.3.1 Global Mucin 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mucin 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mucin 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mucin 1 by Application
  1. 5.1 Mucin 1 Market by Application
  2. 5.1.1 Colon Cancer
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Prostate Cancer
  5. 5.1.4 Breast Cancer
  6. 5.1.5 Others
  7. 5.2 Global Mucin 1 Market Size by Application
  8. 5.2.1 Global Mucin 1 Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Mucin 1 Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Mucin 1 Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Mucin 1 Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Mucin 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Mucin 1 Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Mucin 1 Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Mucin 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck KGaA
  2. 6.1.1 Merck KGaA Company Information
  3. 6.1.2 Merck KGaA Business Overview
  4. 6.1.3 Merck KGaA Mucin 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck KGaA Mucin 1 Product Portfolio
  6. 6.1.5 Merck KGaA Recent Developments
  7. 6.2 Vaxil Bio Therapeutics Ltd
  8. 6.2.1 Vaxil Bio Therapeutics Ltd Company Information
  9. 6.2.2 Vaxil Bio Therapeutics Ltd Business Overview
  10. 6.2.3 Vaxil Bio Therapeutics Ltd Mucin 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Vaxil Bio Therapeutics Ltd Mucin 1 Product Portfolio
  12. 6.2.5 Vaxil Bio Therapeutics Ltd Recent Developments
  13. 6.3 Transgene SA
  14. 6.3.1 Transgene SA Company Information
  15. 6.3.2 Transgene SA Business Overview
  16. 6.3.3 Transgene SA Mucin 1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Transgene SA Mucin 1 Product Portfolio
  18. 6.3.5 Transgene SA Recent Developments
  19. 6.4 Minerva Biotechnologies Corp
  20. 6.4.1 Minerva Biotechnologies Corp Company Information
  21. 6.4.2 Minerva Biotechnologies Corp Business Overview
  22. 6.4.3 Minerva Biotechnologies Corp Mucin 1 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Minerva Biotechnologies Corp Mucin 1 Product Portfolio
  24. 6.4.5 Minerva Biotechnologies Corp Recent Developments
  25. 6.5 GeoVax Labs Inc
  26. 6.5.1 GeoVax Labs Inc Company Information
  27. 6.5.2 GeoVax Labs Inc Business Overview
  28. 6.5.3 GeoVax Labs Inc Mucin 1 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GeoVax Labs Inc Mucin 1 Product Portfolio
  30. 6.5.5 GeoVax Labs Inc Recent Developments
  31. 6.6 Etubics Corp
  32. 6.6.1 Etubics Corp Company Information
  33. 6.6.2 Etubics Corp Business Overview
  34. 6.6.3 Etubics Corp Mucin 1 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Etubics Corp Mucin 1 Product Portfolio
  36. 6.6.5 Etubics Corp Recent Developments
  37. 6.7 Boehringer Ingelheim GmbH
  38. 6.7.1 Boehringer Ingelheim GmbH Company Information
  39. 6.7.2 Boehringer Ingelheim GmbH Business Overview
  40. 6.7.3 Boehringer Ingelheim GmbH Mucin 1 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Boehringer Ingelheim GmbH Mucin 1 Product Portfolio
  42. 6.7.5 Boehringer Ingelheim GmbH Recent Developments
  43. 6.8 Bavarian Nordic A/S
  44. 6.8.1 Bavarian Nordic A/S Company Information
  45. 6.8.2 Bavarian Nordic A/S Business Overview
  46. 6.8.3 Bavarian Nordic A/S Mucin 1 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bavarian Nordic A/S Mucin 1 Product Portfolio
  48. 6.8.5 Bavarian Nordic A/S Recent Developments
  49. 6.9 Akshaya Bio Inc
  50. 6.9.1 Akshaya Bio Inc Company Information
  51. 6.9.2 Akshaya Bio Inc Business Overview
  52. 6.9.3 Akshaya Bio Inc Mucin 1 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Akshaya Bio Inc Mucin 1 Product Portfolio
  54. 6.9.5 Akshaya Bio Inc Recent Developments
7 North America by Country
  1. 7.1 North America Mucin 1 Sales by Country
  2. 7.1.1 North America Mucin 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mucin 1 Sales by Country (2021-2026)
  4. 7.1.3 North America Mucin 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mucin 1 Market Size by Country
  6. 7.2.1 North America Mucin 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mucin 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Mucin 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mucin 1 Sales by Country
  2. 8.1.1 Europe Mucin 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mucin 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Mucin 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mucin 1 Market Size by Country
  6. 8.2.1 Europe Mucin 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mucin 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mucin 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mucin 1 Sales by Country
  2. 9.1.1 Asia-Pacific Mucin 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mucin 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mucin 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mucin 1 Market Size by Country
  6. 9.2.1 Asia-Pacific Mucin 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mucin 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mucin 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mucin 1 Sales by Country
  2. 10.1.1 South America Mucin 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mucin 1 Sales by Country (2021-2026)
  4. 10.1.3 South America Mucin 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mucin 1 Market Size by Country
  6. 10.2.1 South America Mucin 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mucin 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Mucin 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mucin 1 Sales by Country
  2. 11.1.1 Middle East and Africa Mucin 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mucin 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mucin 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mucin 1 Market Size by Country
  6. 11.2.1 Middle East and Africa Mucin 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mucin 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mucin 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mucin 1 Value Chain Analysis
  2. 12.1.1 Mucin 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mucin 1 Production Mode & Process
  7. 12.2 Mucin 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mucin 1 Distributors
  10. 12.2.3 Mucin 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst